Bio Rad Laboratories Inc/ US0905722072 /
| 05/06/2024 22:10:00 | Chg. +0.68 | Volume | Bid10:09:52 | Ask10:09:52 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 289.10USD | +0.24% | 154,158 Turnover: 21.3 mill. |
115.64Bid Size: 200 | 305.30Ask Size: 100 | 6.78 bill.USD | - | - |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 429.4000 | 428.8360 | 437.6900 | 488.6140 | 493.4960 | ||||||
| Intangible Assets | 266.2000 | 254.2280 | 214.0260 | 161.6090 | 174.1130 | ||||||
| Long-Term Investments | - | 389.3090 | 719.8400 | 830.7900 | 1,027.7360 | ||||||
| Fixed Assets | - | 1,624.9110 | 1,933.9460 | 2,005.9800 | 2,296.3510 | ||||||
| Inventories | 501.3000 | 470.9970 | 490.2240 | 524.9610 | 594.8040 | ||||||
| Accounts Receivable | 422.7000 | 377.6400 | 391.4850 | 372.3480 | 464.8470 | ||||||
| Cash and Cash Equivalents | 331.6000 | 413.2510 | 457.5490 | 456.2640 | 383.8240 | ||||||
| Current Assets | 1,747.9000 | 1,716.3670 | 1,777.5960 | 1,844.5240 | 1,976.6490 | ||||||
| Total Assets | 3,388.8000 | 3,341.2780 | 3,711.5420 | 3,850.5040 | 4,273 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 148.5000 | 128.6080 | 122.3910 | 133.1090 | 135.1820 | ||||||
| Long-term debt | - | 435.7100 | 435.7070 | 434.1860 | 434.6000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 162.1000 | 154.9000 | 233.5000 | 222.9000 | 222.2000 | ||||||
| Liabilities | 1,202.1000 | 1,156.1230 | 1,221.0390 | 1,263.7450 | 1,342.7500 | ||||||
| Share Capital | .0030 | .0020 | .0020 | .0020 | .0020 | ||||||
| Total Equity | 2,186.7000 | 2,185.1550 | 2,490.5030 | 2,586.7590 | 2,930.2500 | ||||||
| Minority Interests | 0.0000 | - | - | - | - | ||||||
| Total liabilities equity | 3,388.8000 | 3,341.2780 | 3,711.5420 | 3,850.5040 | 4,273 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,132.7000 | 2,175.0440 | 2,019.4410 | 2,068.1720 | 2,160.2000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 169.5000 | 149.9840 | 166.7080 | 53.1940 | 116.6500 | ||||||
| Interest Income | -61.3000 | 22.1310 | 21.6920 | 21.9420 | 21.9140 | ||||||
| Income Before Taxes | 112.4000 | 131.5570 | 145.8470 | 41.5600 | 97.8000 | ||||||
| Income Taxes | 34.6000 | -42.7120 | -32.7540 | -13.4350 | 24.4000 | ||||||
| Minority Interests Profit | -.0200 | - | - | - | - | ||||||
| Net Income | 77.8000 | 88.8450 | 113.0930 | 28.1250 | 122.2000 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 175.5000 | 273.3120 | 186.2100 | 216.4330 | 103.9000 | ||||||
| Cash Flow from Investing Activities | -5.4000 | -190.5110 | -166.8690 | -213.8800 | -175.5720 | ||||||
| Cash Flow from Financing | -311.7000 | 11.6890 | 8.5810 | 9.0200 | .3410 | ||||||
| Decrease / Increase in Cash | -131.8000 | 81.7000 | 44.2980 | -1.2850 | -72.4400 | ||||||
| Employees | 7,750 | 7,600 | 7,700 | 8,250 | 8,150 | ||||||
